Beta Bionics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $20,440 | $16,704 | $8,350 | $3,093 |
Gross Profit | 11,689 | 8,913 | 5,062 | 1,225 |
EBITDA | -12,805 | -10,670 | -8,074 | -8,470 |
EBIT | -13,037 | -10,977 | -8,367 | -8,782 |
Net Income | -18,108 | -9,736 | -18,848 | -8,680 |
Net Change In Cash | 20,440 | 16,704 | 8,350 | 3,093 |
Free Cash Flow | -14,840 | -6,660 | ||
Cash | 30,432 | 17,481 | 26,566 | |
Basic Shares | 6,665 | 6,264 | 6,027 | 5,062 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $65,124 | $11,995 | $179 |
Gross Profit | 35,888 | 6,308 | 179 |
EBITDA | -44,100 | -34,624 | -63,399 |
EBIT | -45,251 | -35,850 | -64,744 |
Net Income | -54,756 | -44,099 | -64,751 |
Net Change In Cash | 65,124 | 11,995 | 179 |
Free Cash Flow | -51,668 | -32,847 | -60,980 |
Cash | 30,432 | 26,566 | 27,675 |
Basic Shares | 6,365 | 5,303 | 4,997 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.41 |
